Grant Recipients

Elizabeth Mullen, MD

Dana-Farber Cancer Institute

Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling

Holly Meany, MD

Children's National Medical Center

Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors

Loretta Lau, MD

The Children's Hospital at Westmead

Alternative Lengthening of Telomeres in Neuroblastoma

Jessica Panzer, M.D., Ph.D. and Miriam Rosenberg, Ph.D.

Children's Hospital of Philadelphia

Autoantigen discovery in OMAS-an innovative multidisciplinary approach

Austin Brown, PhD

Baylor College of Medicine, Houston TX

Genetic Determinants of Neuropsychological Performance Following Treatment for Pediatric Embryonal Brain Tumors

Muller Fabbri, MD, PhD

Children's Hospital Los Angeles/University of Hawaii

miRNAs secreted by tumor associated macrophages and resistance in Neuroblastoma

Theodore Nicolaides, MD

University of California San Francisco

Immunotherapy and targeted therapy in MAPK -activated pediatric gliomas

Kevin Jones, MD

University of Utah

Role of MITF in Clear Cell Sarcomagenesis

Kira Bona, MD, MPH

Dana-Farber Cancer Institute, Harvard

Development of a Material Hardship Intervention

Prof. Dr. Franz Blaes

Justus-Liebig-University, Germany

Modification of onconeuronal antigens in the neuroblastoma of paraneoplastic OMS by free RNA

Ranjit S. Bindra, MD, PhD

Yale University School of Medicine

Small Molecule Screening for Novel Rhabdoid Tumor Inhibitors

Gregory J. Aune, MD, PhD

UT Health Science Center San Antonio

Pre-clinical Evaluation of Anthracycline Equivalency

Awarded in partnership with Insomniac Cares